Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial.
暂无分享，去创建一个
L. Qin | C. Antonescu | S. Singer | G. Schwartz | W. Tap | M. Gounder | P. Chi | A. Koff | A. Crago | M. Dickson | M. Keohan | Jonathan Landa | S. D’Angelo